Wird geladen...
Crizotinib-induced pancreatic pseudocyst: a novel adverse event
Crizotinib is a tyrosine kinase inhibitor that demonstrates a dramatic tumour response in patients with advanced non-small cell lung cancers harbouring anaplastic lymphoma kinase (ALK) rearrangement. The pancreatic cyst has never been reported in patients who received crizotinib, whereas crizotinib-...
Gespeichert in:
| Veröffentlicht in: | BMJ Case Rep |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567757/ https://ncbi.nlm.nih.gov/pubmed/26351314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-211556 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|